Ruixia X. Guo
No.1 East Jianshe Road
Zhengzhou, 450052, China
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 118 publications
Analyzing Global Trends in Uterine Prolapse Burden: A Comprehensive Study of Incidence and DALYs Across 204 Countries from 1990 to 2021.
Journal: International journal of women's health
Published: March 27, 2026
Oncological and reproductive outcomes in patients with malignant transformation of ovarian mature cystic teratoma
Journal: Zhonghua fu chan ke za zhi
Published: March 22, 2026
Unveiling GSPT1 as a crucial prognostic biomarker and therapeutic vulnerability in breast cancer.
Journal: Scientific reports
Published: February 05, 2026
Recent progress and therapeutic strategies in the treatment of cervical neuroendocrine neoplasms (Review).
Journal: International journal of molecular medicine
Published: January 20, 2026
Predicting postoperative recurrence and survival in malignant ovarian germ cell tumors: a single-center retrospective cohort study and nomogram development.
Journal: Frontiers in oncology
Published: December 16, 2025
Sentinel node mapping with carbon nanoparticles versus lymphadenectomy in early cervical cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 21, 2025
Natural Killer Cells in Uterine Adenomyosis: Immunological Mechanisms and Therapeutic Perspectives.
Journal: Journal of immunology research
Published: October 14, 2025
Preoperative assessment of tumor size by MRI and ultrasound in cervical cancer: a large-scale retrospective comparative study.
Journal: Archives of gynecology and obstetrics
Published: October 07, 2025
Pegylated liposomal doxorubicin plus carboplatin versus paclitaxel plus carboplatin as first-line therapy for epithelial ovarian cancer (CGCS-04): a multicenter, randomized clinical trial.
Journal: Therapeutic advances in medical oncology
Published: September 21, 2025
Efficacy and safety of GS1-144, a novel neurokinin 3 receptor antagonist, for moderate-to-severe vasomotor symptoms associated with menopause in Chinese women: a randomized, double-blind, placebo-controlled phase 2 trial.
Journal: Menopause (New York, N.Y.)
Published: August 28, 2025
A multicenter, prospective, non-interventional drug intensive monitoring study of olaparib in a large real-world Chinese patient cohort with ovarian cancer (DIM-OC).
Journal: Journal of ovarian research
Published: August 12, 2025
Near infrared II excitation conjugated polymers-based phototheranostic nanoplatform for hyperthermia-enhanced ferroptosis and immunotherapy.
Journal: Materials today. Bio
Published: August 05, 2025
Last Updated: 09/26/2026